1. Home
  2. QS vs AMRX Comparison

QS vs AMRX Comparison

Compare QS & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QuantumScape Corporation

QS

QuantumScape Corporation

HOLD

Current Price

$6.58

Market Cap

4.3B

ML Signal

HOLD

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$17.01

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QS
AMRX
Founded
2010
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
4.0B
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
QS
AMRX
Price
$6.58
$17.01
Analyst Decision
Hold
Strong Buy
Analyst Count
6
5
Target Price
$9.38
$15.60
AVG Volume (30 Days)
22.8M
2.2M
Earning Date
04-22-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
19.15
157.89
EPS
N/A
0.19
Revenue
N/A
N/A
Revenue This Year
N/A
$4.48
Revenue Next Year
$1,827.70
$7.13
P/E Ratio
N/A
$89.53
Revenue Growth
N/A
N/A
52 Week Low
$5.90
$7.67
52 Week High
$19.07
$17.86

Technical Indicators

Market Signals
Indicator
QS
AMRX
Relative Strength Index (RSI) 39.86 68.98
Support Level $5.90 $12.46
Resistance Level $7.21 $17.86
Average True Range (ATR) 0.49 0.54
MACD -0.06 -0.13
Stochastic Oscillator 10.90 54.92

Price Performance

Historical Comparison
QS
AMRX

About QS QuantumScape Corporation

QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles and other applications. The company's solid-state lithium-metal battery technology is designed to offer greater energy density, faster charging, and enhanced safety. Its battery cells have none of the host materials used in conventional nodes. The company operates in one operating segment only.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: